TGF-β1, which is frequently elevated in CF patients, reduces CFTR mRNA and protein level in non-CF HBE cells. TGF-β1 also impairs functional rescue of △508-CFTR suggesting it may interfere with therapies aiming at correcting the processing defect of △508-CFTR. Here, TGFB1 is linked to cystic fibrosis.